Monika Matti

General Secretary at Vifor Pharma AG

Monika Matti

Monika Matti

General Secretary at Vifor Pharma AG

Biography

Ms. Monika Matti is Corporate Secretary at Novartis AG.She received her graduate degree from the University of Bern.

Overview
RelSci Relationships

89

Relationships
RelSci Relationships are individuals Monika Matti likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice Chairman at Vifor Pharma AG

Relationship likelihood: Average

Director & Head-Investor Relations at Vifor Pharma AG

Relationship likelihood: Average

Head of Legal at Vifor Pharma AG

Relationship likelihood: Average

Chief Executive Officer, Galenica Santé at Vifor Pharma AG

Relationship likelihood: Average

Chief Executive Officer, Vifor Pharma at Vifor Pharma AG

Relationship likelihood: Average

President & Chief Executive Officer at Hansa Medical AB

Relationship likelihood: Average

Chief Medical Officer at Vifor Pharma AG

Relationship likelihood: Average

Secretary at Vifor Pharma AG

Relationship likelihood: Average

Chief Financial Officer & Head-Investor Relations at Galenica AG

Relationship likelihood: Average

Former Manager-Senior External Communications at Vifor Pharma AG

Relationship likelihood: Average

Paths to Monika Matti
Potential Connections via
Relationship Science
You
Monika Matti
General Secretary at Vifor Pharma AG
Education

The foundations of the University of Bern were laid in the 16th century, when the Reformation made it necessary for new priests to be educated in a higher education establishment. In 1805, as part of the reorganization of higher education, the Bern government converted the former School of Theology into an Academy with four faculties. Thus, not only ministers but also lawyers and physicians could complete their entire education in Bern. The University of Bern offers top quality across the board: it enjoys special recognition in leading-edge disciplines, is reputed for the excellent quality of its teaching, offers a delightful setting, and a campus environment intimately linked to the social, economic and political life of the city. The university's comprehensive offering includes 8 faculties, some 160 institutes, 43 Bachelor- and 96 Masterprogrammes, Ph.D. in all disciplines and more than 200 executive programmes. Courses include theology, humanities, law, the economic and social sciences, medicine, veterinary medicine and sciences. With 16,000 students, it is of mid-range size among Swiss universities. Unlike the bigger institutions, it retains a human dimension and a warm and friendly atmosphere. The central geographic location and its attractive programmes, draw students from all Switzerland's language communities and from abroad. Fees remain very affordable and there is a vast choice of rented accommodation. The University of Bern academic and research organisation prides itself on its interdisciplinarity, exemplified by its strategic research centres (Fundamental Physics; Biomedical Engineering; Cognition, Learning and Memory; Development & Environment; Space and Habitability; Climate Change and World Trade) and by its four National Centres of Competence in Research: “Climate”, “World Trade Regulation”, and “North-South” (sustainable development), and TransCure. Additionally it shares the NCCR «MUST» (Molecular Ultrafast Sciences and Technology / experimental physics) with the ETH Zurich. The University is actively involved in a wide range of European and worldwide research projects, notably in the field of Space Research and Dental Medicine. During the academic year, the university offers some 300 courses, training sessions and competitions in more than 90 sports disciplines, ranging from Ragga Hip Hop to paragliding. Students are invited to join in any of the numerous groups and associations such as the Bern University Theatre, the Uni Big Band or the university choir; they can take part in many interest groups or fraternities. Most of the institutes are located in the Länggasse, a lively student quarter that offers a wide range of places to eat and drink: snack bars, restaurants and cafes are an invitation to wind down. The railway station and city centre with an abundance of shops are just a few minutes' walk from the different university buildings. The city of Bern is listed among the cities that offer the best quality of life in the world. The people of Bern are welcoming and peaceable, and the old town of Bern, nestling in a breath-taking setting surrounded by the Swiss Alps, is listed as a UNESCO world heritage site. The Swiss capital also has an outstandingly broad range of cultural activities. There are plenty of green areas in which to relax, and, for the local, there is nothing more vivifying than a daily dip in the Aare river.

Career History
General Secretary
Current

Vifor Pharma AG, formerly Galenica AG, is a global pharmaceuticals company, which engages in the research, development, production, and marketing of pharmaceutical products in iron deficiency, nephrology, and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures, and markets pharmaceutical products for precision patient care. The Group consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Corporate Secretary
2006 - Prior

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations

Monika Matti is affiliated with Vifor Pharma AG, Novartis AG

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Monika Matti. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Monika Matti's profile does not indicate a business or promotional relationship of any kind between RelSci and Monika Matti.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/monika-matti-4344687
  • https://relationshipscience.com/person/monika-matti-4344687